Trials / Terminated
TerminatedNCT00500084
Phase III ALTU-135 CP Safety Trial
An Open-Label Clinical Study Evaluating the Long Term Safety of ALTU-135 in the Treatment of Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis or Pancreatectomy
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Anthera Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, single-arm clinical study investigating the long-term safety of ALTU-135 treatment in Chronic Pancreatitis (CP) patients with exocrine Pancreatic Insufficiency (PI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Liprotamase | Administered orally |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 2007-07-12
- Last updated
- 2014-10-24
Locations
11 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00500084. Inclusion in this directory is not an endorsement.